Webinar replay

Building a Business Development Powerhouse

Learn how Eli Lilly and Ipsen transformed their business development departments into powerhouses for partnerships.

This post is a panel discussion featuring expert insights from:
  • Tim Noblitt, Director, Corporate Business Development at Eli Lilly
  • Chris Vlahos, Global Head of Rare Disease External Innovation at Ipsen
Watch this replay to hear their insights and learn:
  • How to organize your external innovation team and manage their activities,
  • Strategies for finding external innovation - and how to be found if you have an asset or technology available for partnering,
  • Key metrics for evaluating and improving your performance,
  • How to accelerate business development and partnering.
Presented by:
Tim Noblitt
Director, Corporate Business Development
Eli Lilly
Chris Vlahos
Global Head of Rare Disease External Innovation

Please complete the form below

All fields marked with a * are required.

By submitting this form, you agree to the storing and processing of your
personal data by Inova as detailed in the Privacy Statement.

About Inova

Inova accelerates the find, deal, and collaborate phases of biopharma partnering. Its market-leading platform is used by 60% of the world’s top 50 pharma companies to source and manage their opportunities efficiently, and its technology powers more than 50,000 partnering meetings each year at the world's most important biopharma partnering conferences, including the BIO International Convention.
With subsidiaries Labiotech and IN-PART, Inova reaches more than 100,000 readers in life sciences a month and connects a network of 6,500 industry players and academic organizations.